Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in an outbreak of SARS-CoV-2
<p>In COVID-19, hypertension, diabetes mellitus, coronary artery disease, and immunosuppression are comorbid conditions most often associated with poor prognosis. Angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers are widely used in the treatment of these diseases. T...
Saved in:
Main Author: | Didar Yanardag Acik (Author) |
---|---|
Format: | Book |
Published: |
Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,
2020-07-02.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PERBANDINGAN EFEKTIVITAS PENGGUNAAN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR DAN ANGIOTENSIN RECEPTOR BLOCKER TERHADAP LUARAN KLINIS PASIEN INFARK MIOKARD AKUT (SYSTEMATIC REVIEW)
by: Chitra Tsania Purna Putri,
Published: (2022) -
PENGARUH PENGGUNAAN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR DAN ANGIOTENSIN RECEPTOR BLOCKER TERHADAP MORTALITAS PASIEN COVID-19 DENGAN KOMORBIDITAS PENYAKIT KARDIOVASKULAR TINJAUAN SISTEMATIS
by: Aulia Setya Nurrachmah,
Published: (2021) -
The association between copy number variant of Angiotensin Converting Enzyme gene and the risk of Ascending Aortic Aneurysm in Bicuspid and Tricuspid Aortic Valve
by: Azadeh Motavalli Naeini, et al.
Published: (2019) -
In silico design of angiotensin-converting enzyme 2 (ACE2) recombinant protein to block the S1 protein pathway of COVID-19 virus
by: Yaser Ghazi
Published: (2020) -
Outbreak of a new coronavirus (SARS-CoV-2) infection and pollen exposure
by: Akira Awaya, et al.
Published: (2021)